|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
3/5/2012 6:04:27 AM
BOSTON--(BUSINESS WIRE)--The Life Sciences Practice of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented its client, Boston Biomedical, Inc. (BBI), in the company’s definitive agreement to be acquired by Dainippon Sumitomo Pharma Co., Ltd. (DSP). Under the terms of the agreement, DSP will acquire BBI for up to $2.63 billion in total, which includes $200 million upfront, up to $540 million in development milestone payments, and up to $1.89 billion in sales milestone payments.
|
|
|
|
|
|
|
|
|
|
|